Antibiotic polymeric nanoparticles for biofilm-associated infection therapy

Methods in Molecular Biology

Volumn 1147, Issue , 2014, Pages 227-238

  Cheow, Wean Sin ^a   Hadinoto, Kunn ^a  

^a NONE

Author keywords

Antibiofilm; Antimicrobial testing; Lipid polymer hybrid nanoparticles; PLGA

Indexed keywords

LEVOFLOXACIN; NANOPARTICLE; POLYELECTROLYTE; ANTIINFECTIVE AGENT; LIPID; POLYMER;

ANTIBIOTIC THERAPY; ARTICLE; BIOCOMPATIBILITY; BIOFILM; CIRCULATION TIME; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; INFECTION; POLYMERIZATION; PRIORITY JOURNAL; STATIC ELECTRICITY; BACTERIAL PHENOMENA AND FUNCTIONS; CHEMISTRY; DRUG EFFECT; MICROBIAL SENSITIVITY TEST; TIME;

ANTI-BACTERIAL AGENTS; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOFILMS; DRUG DELIVERY SYSTEMS; LIPIDS; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; POLYMERS; TIME FACTORS;

EID: 84910156033     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0467-9_16     Document Type: Article

References (12)

1. Stewart PS (2002) Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 292:107–113
2. Meers P, Neville M, Malinin V et al (2008) Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother 61:859–868
3. Albanese A, Tang PS, Chan WCW (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1–16
4. Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505–515
5. Peer D, Karp JM, Hong S et al (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–760
6. Zhang L, Chan JM, Gu FX et al (2008) Self-assembled lipid–polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano 2:1696–1702
7. Cheow WS, Hadinoto K (2012) Green amorphous nanoplex as a new supersaturating drug delivery system. Langmuir 28: 6265–6275
8. Govender T, Stolnik S, Garnett MC et al (1999) PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 57:171–185
9. Sung J, Padilla D, Garcia-Contreras L et al (2009) Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm Res 26: 1847–1855
10. Cheow WS, Hadinoto K (2011) Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles. Colloids Surf B Biointerfaces 85:214–220
11. Harrison J, Ceri H, Yerly J et al (2006) The use of microscopy and three-dimensional visualization to evaluate the structure of microbial biofilms cultivated in the calgary biofilm device. Biol Proced Online 8: 194–215
12. Ceri H, Olson ME, Stremick C et al (1999) The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37: 1771–1776